Tekmira Pharmaceuticals disclosed that board member Kenneth Galbraith has resigned from the company.
Tekmira said that, to its knowledge, the departure was "not the result of any disagreement with the corporation relating to [its] operations, policies, or practices."
Galbraith joined Tekmira's board of directors in January 2010. He is currently a general partner at Ventures West, handling that firm's biotechnology practice.